Cargando…
Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?
Since the first report that intensive insulin therapy reduced mortality in selected surgical critically ill patients, lowering of blood glucose levels has been recommended as a means of improving patient outcomes. In this initial Leuven trial, blood glucose control by protocol using insulin was appl...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689479/ https://www.ncbi.nlm.nih.gov/pubmed/19435472 http://dx.doi.org/10.1186/cc7755 |